CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 1:00:09 Webinar: Avidity Biosciences – Topline Data from EXPLORE44® Clinical Trial 4 months ago Research & Clinical Trial Webinars,Webinars AOC 1044,avidity biosciences,del-zota 47:43 Webinar: Capricor Therapeutics – Update on Deramiocel for Cardiomyopathy in Patients with Duchenne 4 months ago Research & Clinical Trial Webinars,Webinars cap-1002,capricor,cardiac,deramiocel 02:15:11 PPMD’s Duchenne Early Intervention Symposium 4 months ago Webinars newborn screening 01:08:05 Webinar: Solid Biosciences – Update on Gene Therapy Candidate SGT-003 5 months ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 58:14 Webinar: Sevasemten – CANYON Trial Topline Results 7 months ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 1:01:40 Webinar: RGX-202 – AFFINITY DUCHENNE Pivotal Program and Functional Data 8 months ago Research & Clinical Trial Webinars,Webinars gene therapy,RGX-202 51:49 Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion 8 months ago Research & Clinical Trial Webinars,Webinars sgt-003,solid biosciences 56:19 Webinar: Exploring Muscle Regeneration – A New Approach with Satellos 8 months ago Research & Clinical Trial Webinars,Webinars «1234…27»Page 2 of 27